Literature DB >> 11010818

Epidermal growth factor receptor efficiently activates mitogen-activated protein kinase in HeLa cells and Hep2 cells conditionally defective in clathrin-dependent endocytosis.

L E Johannessen1, T Ringerike, J Molnes, I H Madshus.   

Abstract

Epidermal growth factor (EGF)-induced signaling was investigated in cells conditionally defective in clathrin-dependent endocytosis by overexpression of K44A dynamin in HeLa cells and potassium depletion in Hep2 cells. Overexpression of mutant dynamin disrupts high-affinity EGF-EGF receptor (EGFR) interaction (T. Ringerike, E. Stang, L. E. Johannessen, D. Sandnes, F. O. Levy, and I. H. Madshus, 1998, J. Biol. Chem. 273, 16639-16642). However, the EGFR substrates Shc and c-Cbl were as efficiently tyrosine phosphorylated in endocytosis-deficient HeLa cells exhibiting only low-affinity EGFRs as in HeLa cells with intact endocytosis and with both high- and low-affinity EGFRs. Both Raf and mitogen-activated protein kinase (MAPK) were activated to the same extent and with the same kinetics. HeLa cells distributed equally in the cell cycle regardless of EGFR internalization. Upon potassium depletion of Hep2 cells, EGF-induced EGFR endocytosis was inhibited. However, the EGFR and MAPK were efficiently activated by EGF in both the absence and the presence of clathrin-dependent endocytosis. The EGFR was weakly tyrosine phosphorylated by potassium depletion even in the absence of EGF, and this activation resulted in detectable activation of MAPK. Our results demonstrate that internalization of EGFR by clathrin-dependent endocytosis is not required for activation of MAPK. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11010818     DOI: 10.1006/excr.2000.5004

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  17 in total

1.  Internalization-dependent and -independent requirements for transforming growth factor beta receptor signaling via the Smad pathway.

Authors:  Sumedha G Penheiter; Hugh Mitchell; Nandor Garamszegi; Maryanne Edens; Jules J E Doré; Edward B Leof
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

2.  The serine/threonine kinase cyclin G-associated kinase regulates epidermal growth factor receptor signaling.

Authors:  Lei Zhang; Ole Gjoerup; Thomas M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

3.  Suppression of EGFR endocytosis by dynamin depletion reveals that EGFR signaling occurs primarily at the plasma membrane.

Authors:  Leiliane P Sousa; Irit Lax; Hongying Shen; Shawn M Ferguson; Pietro De Camilli; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

4.  Endocytosis separates EGF receptors from endogenous fluorescently labeled HRas and diminishes receptor signaling to MAP kinases in endosomes.

Authors:  Itziar Pinilla-Macua; Simon C Watkins; Alexander Sorkin
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

5.  Growth factor receptor binding protein 2-mediated recruitment of the RING domain of Cbl to the epidermal growth factor receptor is essential and sufficient to support receptor endocytosis.

Authors:  Fangtian Huang; Alexander Sorkin
Journal:  Mol Biol Cell       Date:  2005-01-05       Impact factor: 4.138

6.  Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling.

Authors:  Esther Sook Miin Wong; Chee Wai Fong; Jormay Lim; Permeen Yusoff; Boon Chuan Low; Wallace Y Langdon; Graeme R Guy
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

7.  Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop.

Authors:  Nicole E Willmarth; Andrea Baillo; Michele L Dziubinski; Kristy Wilson; David J Riese; Stephen P Ethier
Journal:  Cell Signal       Date:  2008-10-14       Impact factor: 4.315

Review 8.  Endocytosis and signalling: intertwining molecular networks.

Authors:  Alexander Sorkin; Mark von Zastrow
Journal:  Nat Rev Mol Cell Biol       Date:  2009-09       Impact factor: 94.444

9.  Kinase scaffold repurposing for neglected disease drug discovery: discovery of an efficacious, lapatinib-derived lead compound for trypanosomiasis.

Authors:  Gautam Patel; Caitlin E Karver; Ranjan Behera; Paul J Guyett; Catherine Sullenberger; Peter Edwards; Norma E Roncal; Kojo Mensa-Wilmot; Michael P Pollastri
Journal:  J Med Chem       Date:  2013-05-03       Impact factor: 7.446

10.  N-terminal site-specific mono-PEGylation of epidermal growth factor.

Authors:  Haeshin Lee; Il Ho Jang; Sung Ho Ryu; Tae Gwan Park
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.